A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations
Atavistik Bio, Inc
Atavistik Bio, Inc
Alterome Therapeutics, Inc.
Marengo Therapeutics, Inc.
Hoosier Cancer Research Network
Tesaro, Inc.
Auron Healthcare GmbH